A shadow market for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Investigational Drug Acquiring Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to contact these accounts privately for source information, while also receiving discount codes.
Active Trade on Messaging Platforms
Additionally, a robust trade exists on messaging services, where communities with numerous of participants share “before and after” photos, injection guides and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Experts Express Worries
Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to users injecting products of unknown origin.
Some experts said the popularity for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Content Removal
According to TikTok, the service has taken down problematic content and prohibited related hashtags and query recommendations. The organization stated it was committed to keeping the service safe and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Investigations also discovered groups with up to 9,000 participants selling retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, filled with images of weight loss, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within minutes of entering one group, a seller shared contact information, where most transactions take place. The vendor provided an guidebook and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.
Item Details and Pricing
Inside these groups, messages show black plastic packages with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service said it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has already encountered individuals injured by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to potentially serious medical dangers”.
